Serevent Diskus (salmeterol xinafoate inhalation powder)
New indication: Long-term, twice-daily treatment of bronchospasm associated with COPD
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
